KojoX™ – Transforming the CDMO Industry with a Patient-Centric Approach Fueled by Innovation
December 2, 2024
John Stewart, Vice President KojoX Strategy, serves as part of the Global Strategic Business Services group at FUJIFILM Diosynth Biotechnologies. His responsibilities include the execution of the Company’s novel KojoXTM Strategy. John is an executive with 30 years tenure in the pharmaceuticals industry with a background in international multi-site leadership of both small molecule and biologics manufacture and supply networks and with responsibility for internal and external manufacturing of clinical and commercial stage biologics.
Continue reading